Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Market Closed - BME 16:35:22 25/09/2026 BST			5-day change	1st Jan Change
59.15 ^EUR	-0.59%		+2.60%	-6.85%

07-23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
07-23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Consensus
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.45B		BBB
ELI LILLY AND COMPANY	1,055B		A
JOHNSON & JOHNSON	654B	-	BBB	-		-
ABBVIE INC.	467B		AAA			-
ROCHE HOLDING AG	348B		AA
NOVARTIS AG	275B		AAA
ASTRAZENECA PLC	258B		A
AMGEN INC.	224B		A
GILEAD SCIENCES, INC.	187B		AA
NOVO NORDISK A/S	171B		BBB
PFIZER INC.	163B		A
VERTEX PHARMACEUTICALS INCORPORATED	133B		AA
BRISTOL-MYERS SQUIBB COMPANY	128B		A
GSK PLC	98.2B		AA
SANOFI	98.02B		A
CHUGAI PHARMACEUTICAL CO., LTD.	69.17B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	60.57B		AA
BAYER AG	56B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	45.67B		A		-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	44B		AA
Average	226.93B		AA
Weighted average by Cap.			AA